KIAMESHA JONES: Open Payments
NPI 1518733492 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $207 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $225 |
| AstraZeneca Pharmaceuticals LP | 2 | $205 |
| Janssen Biotech, Inc. | 1 | $134 |
| Incyte Corporation | 1 | $132 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 3 | $42 |
| Verastem, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $21 |
Products named: DATROWAY, RYBREVANT, Jakafi, Orserdu, Trodelvy, ALUNBRIG, Enhertu, ZEJULA.
Industry payments across FL — which companies pay providers there.
